Literature DB >> 19841173

Generation of B cell memory to the bacterial polysaccharide alpha-1,3 dextran.

Jeremy B Foote1, John F Kearney.   

Abstract

B1b B cells generate a novel form of memory and provide Ab mediated-protection to persisting bacterial pathogens. To understand how B1b B cells establish memory to polysaccharide Ags, we studied an oligoclonal B cell response to alpha-1,3 dextran (DEX) expressed on Enterobacter cloacae. B cells specific for DEX enrich in the marginal zone (MZ) and B1b B cell populations. After E. cloacae immunization, MZ B cells were responsible for the generation of initial peak DEX-specific Ab titers, whereas, DEX-specific B1b B cells expanded and played an important role in boosted production of DEX-specific Ab titers upon E. cloacae rechallenge. Cell transfer experiments demonstrate that B1b B cells possess the capacity for both robust proliferation and plasma cell differentiation, thus distinguishing themselves from MZ B cells, which uniformly commit to plasma cell differentiation. These results define B1b B cells as the principal reservoir for memory to bacterial-associated polysaccharide Ags.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841173      PMCID: PMC3235742          DOI: 10.4049/jimmunol.0902473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory".

Authors:  F Martin; J F Kearney
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

2.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

Review 3.  Marginal-zone B cells.

Authors:  Flavius Martin; John F Kearney
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

Review 4.  The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.

Authors:  A Zandvoort; W Timens
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

5.  Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi.

Authors:  H Kumar; A Belperron; S W Barthold; L K Bockenstedt
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 6.  Vaccines against polysaccharide antigens.

Authors:  G B Lesinski; M A Westerink
Journal:  Curr Drug Targets Infect Disord       Date:  2001-11

7.  Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.

Authors:  Gregory D Wiens; McKay Brown; Marvin B Rittenberg
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

8.  Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.

Authors:  Leah E Cole; Yang Yang; Karen L Elkins; Ellen T Fernandez; Nilofer Qureshi; Mark J Shlomchik; Leonard A Herzenberg; Leonore A Herzenberg; Stefanie N Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

9.  Autoreactive B cells in the marginal zone that express dual receptors.

Authors:  Yijin Li; Hui Li; Martin Weigert
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

10.  Germinal centers without T cells.

Authors:  C G de Vinuesa; M C Cook; J Ball; M Drew; Y Sunners; M Cascalho; M Wabl; G G Klaus; I C MacLennan
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  37 in total

1.  Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.

Authors:  Karen M Haas
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 2.  B-1 lymphocytes in mice and nonhuman primates.

Authors:  Karen M Haas
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

Review 3.  B cells and atherosclerosis.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

4.  Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.

Authors:  James B Case; Rachel H Bonami; Lindsay E Nyhoff; Hannah E Steinberg; Allison M Sullivan; Peggy L Kendall
Journal:  J Immunol       Date:  2015-06-01       Impact factor: 5.422

5.  Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.

Authors:  Rebekah E Wharton; Emily K Stefanov; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

6.  Pulmonary α-1,3-Glucan-Specific IgA-Secreting B Cells Suppress the Development of Cockroach Allergy.

Authors:  Preeyam S Patel; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

7.  Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.

Authors:  Gregory S Dickinson; Guizhi Sun; Richard J Bram; Kishore R Alugupalli
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

8.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

9.  An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Authors:  James P Phipps; Karen M Haas
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

10.  CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Authors:  Karen M Haas; Kristen L Johnson; James P Phipps; Cardinal Do
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.